Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | 10.00 | 10.00 |
| Reserves & surplus | 743.74 | 558.79 | 464.69 | 429.64 | 388.04 |
| Loan funds | |||||
| Secured loans | 5.00 | - | - | 77.33 | 66.31 |
| Unsecured loans | - | - | - | - | - |
| Total | 789.67 | 599.72 | 505.63 | 557.90 | 505.28 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 234.33 | 224.19 | 196.31 | 173.02 | 150.45 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 98.81 | 95.11 | 81.13 | 70.41 | 62.56 |
| Net block | 135.51 | 129.09 | 115.18 | 102.61 | 87.89 |
| Capital work-in-progress | - | - | - | - | - |
| Investments | 236.51 | 236.07 | 236.07 | 236.07 | 236.07 |
| Net current assets | |||||
| Current assets, loans & advances | 593.59 | 353.40 | 248.52 | 273.30 | 233.32 |
| Less : current liabilities & provisions | 175.94 | 118.84 | 94.15 | 54.09 | 52.01 |
| Total net current assets | 417.65 | 234.56 | 154.37 | 219.21 | 181.32 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 789.67 | 599.72 | 505.63 | 557.90 | 505.28 |
| Notes: | |||||
| Book value of unquoted investments | 236.07 | 236.07 | 236.07 | 236.07 | 236.07 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 114.36 | 115.10 | 140.38 | 30.40 | 11.05 |
| Number of equity sharesoutstanding (Lacs) | 4093.14 | 4093.14 | 4093.14 | 4093.14 | 4093.14 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis